about
Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma.Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects.Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia.Divergent Effects of Dioxin- or Non-Dioxin-Like Polychlorinated Biphenyls on the Apoptosis of Primary Cell Culture from the Mouse Pituitary Gland.Diagnosis and treatment of autoimmune hypophysitis: a short review.Effects of cocaine on the hypothalamic-pituitary-adrenal axis.Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations.The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study.Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy.Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding.Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH.A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease.Cardiac extrinsic apoptotic pathway is silent in young but activated in elder mice overexpressing bovine GH: interplay with the intrinsic pathway.Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study GroupSerum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinomaMild clinical expression of myasthenia gravis associated with autoimmune thyroid diseasesThe course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control studySoluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoidsRelation between therapy for hyperthyroidism and the course of Graves' ophthalmopathyThyroid vascularity is increased in patients with active acromegalySubmandibular salivary gland volume is increased in patients with acromegalyComparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidismThyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonographyThyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormonePrevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseasesIdentification of acromegalic patients at risk of developing colonic adenomasImpact of different cut-off limits of peak GH after GHRH-arginine stimulatory test, single IGF1 measurement, or their combination in identifying adult patients with GH deficiencyPituitary autoimmunity is associated with hypopituitarism in patients with primary empty sellaChanges in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgeryUsefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisolThe beneficial effect of acromegaly control on blood pressure values in normotensive patientsLong-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence studyLower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma
P50
Q33586795-3B3D52A7-FE18-42D2-A228-5E83890B41BCQ34128753-2CC9815E-0AAE-4130-B035-EC29784E8214Q34776728-0D247246-77DA-4ECD-A3F5-5DF7B524534CQ35890596-F2968F13-D337-4012-8200-13754A2CCA76Q37900453-B552010C-F74A-424B-876B-BD46FEFFA31BQ38213852-065E6772-B1FC-468A-9D4D-2C17E42305F0Q39152592-079C4F15-29E3-4812-8AD5-63B636B2A6F8Q40982205-3E3A7319-384F-4326-BE91-A47B984167E4Q46372817-D61E7AB8-C65D-4C7A-B571-29F091E65658Q46528301-657A73ED-83F5-4114-AFCF-F94744CDC851Q47306702-5660A0B3-B780-445C-BED4-756E9EA2E910Q51738572-00FDE300-1A29-42A7-B04E-74E57D06733BQ52651698-28558587-C989-4182-B6D3-2A3D372F9042Q54564410-677C6C4A-8ECD-4F86-A2D8-5903ADCE6852Q64974110-E4866950-2EDC-4BE5-8483-382680DCAE0EQ71477182-8A5BF108-684C-4E54-88F5-DAD08FCC6C61Q72224290-9668130A-5308-4DF4-8C77-021E6665F300Q73047767-7611C7AF-99CD-4CE6-9CB6-86F0223A4252Q73231271-F7F3BBE8-0103-41C6-95CE-026515BE06F1Q73738586-06946D87-998A-4C14-A6F8-D07631C184C0Q74010201-B37C1020-A3E6-45BD-BAA2-E55BAAFEF69EQ74417815-7DCA2D87-A08B-4EAC-A308-AD3311704C38Q74417839-8D77D4F5-5E11-4765-B9C6-9DD186741CE0Q74449481-48F9AFF2-2C7D-4649-9B4B-72AD926F04F1Q77405116-063D3433-1C86-4904-B2BA-E6938A9EF3AEQ79248711-74AA20AB-3715-4B8E-AF9D-4F13DFE977C3Q79886754-7854B7BF-6890-4426-A77C-DAA7AFD9EC88Q82434367-B86DBA40-C45F-4B00-BEBC-FE5F046202D5Q83392340-7DE071F7-52B5-4BD9-8542-9F5A5C08EE7BQ84218635-7F9001E2-7CE7-4725-AEBA-6F48E0EB56F1Q84705663-0893C9AF-3444-48B1-9990-91916A5C6CB3Q85611178-37342138-02A8-42C3-BE8F-144CE5F0D534Q87503280-EC0226F0-0E22-4C31-B63A-D2FF3D6B3B51Q92805376-40F78412-445E-4A26-99B5-C49302961405Q95515963-571921F3-CB98-4874-BAFC-10A7836B8D65
P50
description
researcher ORCID ID = 0000-0001-9911-5366
@en
wetenschapper
@nl
name
Luca Manetti
@ast
Luca Manetti
@en
Luca Manetti
@es
Luca Manetti
@nl
type
label
Luca Manetti
@ast
Luca Manetti
@en
Luca Manetti
@es
Luca Manetti
@nl
prefLabel
Luca Manetti
@ast
Luca Manetti
@en
Luca Manetti
@es
Luca Manetti
@nl
P1153
6701904094
P31
P496
0000-0001-9911-5366